Scientists Identify Potential Therapeutic Target for Multiple Sclerosis

Canadian scientists have identified a potential therapeutic target for multiple sclerosis (MS).

Multiple sclerosis is a disease caused by damage to myelin - the protective covering wrapped around the nerves of the central nervous system (CNS).

Multiple sclerosis - Symptoms - Causes - Diagnosis - Treatment
Multiple sclerosis can be a severely disabling autoimmune disease that affects the myelin or insulating layer of the nerve fibers and typically has remissions and relapses

Using a mouse model, researchers at the Hotchkiss Brain Institute at the University of Calgary have discovered that a molecular switch called EMMPRIN plays an important role in MS.

They explored how in MS, EMMPRIN affects MMPs and the entry of leukocytes into the CNS to result in disease activity.

"In our studies we inhibited EMMPRIN and noticed a reduced intensity of MS-like symptoms in mice," said V. Wee Yong, the study's principal investigator.

Multiple Sclerosis – Treatment to Reduce Symptoms and Modify course of Disease
Multiple sclerosis is treated with drugs that modify the course of the disease, suppress immunity and relieve symptoms.

"Our data suggests that if we target EMMPRIN in patients with MS, we may reduce the injury to the brain and spinal cord caused by immune cells," Yong said.

In addition to working with animal models, the authors also found that EMMPRIN is significantly elevated in the brain lesions of MS patients, indicating its potential significance in the disease.

Cholesterol Compound Not Associated With Multiple Sclerosis - Study
Researchers contradicting to a previous study have found that cholesterol compounds known as oxysterols are not present in any significant amount in multiple sclerosis patients.

The research findings are published in the Jan 12th issue of the Journal of Neuroscience.

Source-ANI

Hypertension Drug To Treat Multiple Sclerosis
Hydralazine, a hypertension drug, could be effective against multiple sclerosis, researchers say, following the discovery of a possible link between the disease and environmental pollutant acrolein.